US 10766864
Morphinan derivatives for the treatment of neuropathic pain
granted A61PA61P25/04
Quick answer
US patent 10766864 (Morphinan derivatives for the treatment of neuropathic pain) held by Nektar Therapeutics expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P25/04